Description
ZLN005increasesexpressionofPPAR-γcoactivator-1α(PGC-1α),exhibitinganti-diabeticactivity.Inanimalmodelsofdiabetes,thiscompoundincreasesactivationofAMPK,stimulatesfatoxidation,andimprovesglucosetoleranceandinsulinsensitivity.
ZLN005increasesexpressionofPPAR-γcoactivator-1α(PGC-1α),exhibitinganti-diabeticactivity.Inanimalmodelsofdiabetes,thiscompoundincreasesactivationofAMPK,stimulatesfatoxidation,andimprovesglucosetoleranceandinsulinsensitivity.
| CasNo. | 49671-76-3 |
|---|---|
| Purity | ≥98% |
| Formula | C17H18N2 |
| FormulaWt. | 250.35 |
| IUPACName | 2-[4-(2-Methyl-2-propanyl)phenyl]-1H-benzimidazole |
| StoreTemp | -20°C |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | Z4552InfoSheetPDF |
|---|
ZhangLN,ZhouHY,FuYY,etal.Novelsmall-moleculePGC-1αtranscriptionalregulatorwithbeneficialeffectsondiabeticdb/dbmice.Diabetes.2013Apr;62(4):1297-307.PMID:23250358.